Janssen publishes positive safety and efficacy data for single-dose COVID-19 vaccine

Friday, 29 January 2021 14:21

Janssen publishes phase 3 trial data from study showing positive safety and efficacy results for its single-dose COVID-19 vaccine Vaccine shown to be 66% effective overall in preventing coronavirus in participants UK has secured 30 million doses with deliveries expected to arrive this year if approved by regulators Janssen today (29 January) published positive data from...Request free trial